Analysis of binding parameters of HIV-1 integrase inhibitors: correlates of drug inhibition and resistance

Article


Loizidou, E., Zeinalipour-Yazdi, C., Christofides, T. and Kostrikis, L. 2009. Analysis of binding parameters of HIV-1 integrase inhibitors: correlates of drug inhibition and resistance. Bioorganic & Medicinal Chemistry. 17 (13), pp. 4806-4818. https://doi.org/10.1016/j.bmc.2009.04.058
TypeArticle
TitleAnalysis of binding parameters of HIV-1 integrase inhibitors: correlates of drug inhibition and resistance
AuthorsLoizidou, E., Zeinalipour-Yazdi, C., Christofides, T. and Kostrikis, L.
Abstract

This study undertook an exploratory data analysis of the binding parameters of HIV-1 integrase inhibitors. The study group involved inhibitors in preclinical development from the diketo acid, pyrroloquinoline and naphthyridine carboxamide families and the most advanced inhibitors Raltegravir and Elvitegravir. Distinct differences were observed in the energetics of binding between the studied classes of inhibitors that also correlated with drug resistant patterns. Quantitative-property–activity-relationships correlated experimental IC50 values to the binding energy and the logarithm of the partition coefficient between n-octanol and water (clog P). The approach followed here serves as an improved basis for the development of ‘second generation’ integrase inhibitors.

LanguageEnglish
PublisherElsevier
JournalBioorganic & Medicinal Chemistry
ISSN0968-0896
Publication dates
Print01 Jul 2009
Publication process dates
Deposited06 Mar 2015
Output statusPublished
Digital Object Identifier (DOI)https://doi.org/10.1016/j.bmc.2009.04.058
Permalink -

https://repository.mdx.ac.uk/item/84z39

  • 10
    total views
  • 0
    total downloads
  • 0
    views this month
  • 0
    downloads this month

Export as